仁和药业：2025年半年度归属于上市公司股东的净利润为290426249.89元

Core Insights - Renhe Pharmaceutical reported a revenue of 1,975,091,476.41 yuan for the first half of 2025, representing a year-on-year decline of 16.46% [2] - The net profit attributable to shareholders of the listed company was 290,426,249.89 yuan, down 13.87% year-on-year [2] Financial Performance - Revenue for the first half of 2025: 1,975.09 million yuan, a decrease of 16.46% compared to the previous year [2] - Net profit for the same period: 290.43 million yuan, reflecting a decline of 13.87% year-on-year [2]